drugset / Trial / NCT03485274

Substance Misuse To Psychiatric Disorders for Cannabis

NCT03485274

RandomizedParallel-groupSingle-blindTreatment

Summary

With the recent availability of vortioxetine, and the surging phenomenon of cannabis misuses amongst young abusers, it is a timely opportunity to conduct an early pharmacotherapy intervention study to offer an evidence-based strategy aiming to stop individuals with cannabis use disorders with depressive or anxiety symptoms, to develop into a more chronic disabling dependence or co-morbid state.

Timeline

Start
2018-07-25
Primary completion
2023-02-28
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vortioxetine Unknown 5 mg Oral
Comparator Vortioxetine Unknown 20 mg Oral